PUMA BIOTECHNOLOGY, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Puma Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Puma Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $20.3M, a 251% increase year-over-year.
  • Puma Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $23.2M.
  • Puma Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $21.6M.
  • Puma Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $2K.
  • Puma Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$29.1M, a 51.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $23.2M $20.3M +$14.5M +251% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $8.72M -$4.53M -$6.66M -313% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $15.4M -$4.82M -$6.22M -444% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $21.6M $12.3M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $5.8M +$6.16M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.13M -$7.25M -77.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.4M +$4.8M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q3 2022 $9.73M -$360K +$44.3M +99.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$34.6M $9.37M +$14.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$49.1M -$3.4M -$19.9M -121% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$29.1M $4.12M +$19.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$48.2M -$44.7M -$13.2M -42% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$35M -$5.11M -$8.5M -250% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$26.5M $16.5M +$33.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$60M -$15M -$3.8M -33.9% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$56.2M -$31.5M -$14.6M -86.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$41.6M $3.4M +$40.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$82.4M -$16.9M -$6.85M -67.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$75.6M -$11.2M +$19.5M +63.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$95.1M -$16.9M -$2.68M -18.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$92.4M -$37.4M +$6.91M +15.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$99.3M -$10.1M +$14.3M +58.6% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$114M -$30.7M +$33.4M +52.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$147M -$14.2M +$63M +81.6% Jul 1, 2018 Sep 30, 2018 10-K 2021-03-01
Q2 2018 -$210M -$44.3M +$33.5M +43% Apr 1, 2018 Jun 30, 2018 10-K 2021-03-01
Q1 2018 -$243M -$24.3M +$48.5M +66.6% Jan 1, 2018 Mar 31, 2018 10-K 2021-03-01
Q4 2017 -$292M -$64.1M +$8.58M +11.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 -$301M -$77.2M -$11.4M -17.3% Jul 1, 2017 Sep 30, 2017 10-K 2020-02-28
Q2 2017 -$289M -$77.8M -$11.2M -16.9% Apr 1, 2017 Jun 30, 2017 10-K 2020-02-28
Q1 2017 -$278M -$72.9M -$1.89M -2.67% Jan 1, 2017 Mar 31, 2017 10-K 2020-02-28
Q4 2016 -$276M -$72.7M -$10.9M -17.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 -$265M -$65.8M -$5.36M -8.88% Jul 1, 2016 Sep 30, 2016 10-K 2019-03-01
Q2 2016 -$260M -$66.6M -$1.9M -2.94% Apr 1, 2016 Jun 30, 2016 10-K 2019-03-01
Q1 2016 -$258M -$71M -$18.5M -35.3% Jan 1, 2016 Mar 31, 2016 10-K 2019-03-01
Q4 2015 -$239M -$61.7M -$14.2M -30% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$225M -$60.4M -$24.6M -68.6% Jul 1, 2015 Sep 30, 2015 10-K 2018-03-09
Q2 2015 -$200M -$64.7M -$25.9M -66.5% Apr 1, 2015 Jun 30, 2015 10-K 2018-03-09
Q1 2015 -$175M -$52.5M -$32.7M -165% Jan 1, 2015 Mar 31, 2015 10-K 2018-03-09
Q4 2014 -$142M -$47.5M -$31.5M -198% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$110M -$35.8M -$21.6M -151% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-01
Q2 2014 -$88.9M -$38.8M -$26.2M -207% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-01
Q1 2014 -$62.7M -$19.8M -$8.01M -68% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-01
Q4 2013 -$54.7M -$15.9M +$5.97M +27.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$60.6M -$14.3M +$11.6M +44.8% Jul 1, 2013 Sep 30, 2013 10-K 2016-02-29
Q2 2013 -$72.2M -$12.7M +$2.1M +14.3% Apr 1, 2013 Jun 30, 2013 10-K 2016-02-29
Q1 2013 -$74.3M -$11.8M +$46K +0.39% Jan 1, 2013 Mar 31, 2013 10-K 2016-02-29
Q4 2012 -$74.4M -$21.9M -$12.1M -123% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$62.3M -$25.9M -$25.5M -7343% Jul 1, 2012 Sep 30, 2012 10-K 2015-03-02
Q2 2012 -$36.8M -$14.8M -$14.7M Apr 1, 2012 Jun 30, 2012 10-K 2015-03-02
Q1 2012 -$22.1M -$11.8M -$11.8M Jan 1, 2012 Mar 31, 2012 10-K 2015-03-02
Q4 2011 -$10.2M -$9.85M -$9.84M Oct 1, 2011 Dec 31, 2011 10-Q 2014-11-10
Q3 2011 -$393K -$347K -$341K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$51.8K -$34.3K* -$31.8K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$20K -$3.94K* Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$7K* Sep 16, 2010 Dec 31, 2010 10-Q 2014-11-10
Q3 2010 -$6.63K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.44K* Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.